Skip to search.
 TSX Down 0.62% TSX Ventures Down 0.53%

More On TTH.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Transition Therapeutics Inc (TTH.TO)

-Toronto
1.07 Up 0.10(10.31%) May 2, 3:30PM EDT
Prev Close:0.97
Open:0.96
Bid:0.98
Ask:1.07
1y Target Est:N/A
Beta:2.79113
Earnings Date:May 10 - May 16 (Est.)
Day's Range:0.96 - 1.08
52wk Range:0.94 - 11.50
Volume:5,304
Avg Vol (3m):18,840
Market Cap:41.60M
P/E (ttm):N/A
EPS (ttm):-0.66
Div & Yield:0.06 (0.20%)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :N/A
Quarterly EPS Est (Jun-15) :N/A
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications primarily in Canada. The company's lead central nervous system drug candidate is ELND005, which has completed a Phas... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback